Ethical and legal challenges of Artificial Intelligence-based medical diagnostics: A perspective
Nabila Rahman
Abstract
Artificial intelligence systems are quickly becoming part of clinical diagnostics in areas like imaging, pathology, genomics, and point-of-care testing. They promise to improve the speed, accuracy, and availability of easy diagnoses. However, integrating them presents significant ethical and legal challenges. Key ethical concerns include algorithmic bias, lack of transparency, known as the black box problem, threats to patient autonomy and consent, data privacy, and trust issues. Legal issues focus on assigning liability, ensuring that regulations fit adaptive algorithms, complying with data protection across different regions, intellectual property rights, and managing cross-border governance. This article highlights common failure modes and suggests practical steps for deploying artificial intelligence diagnostics in an ethical and legal manner. These steps include developing regulatory pathways, requiring bias audits, establishing explainable standards, monitoring throughout the lifecycle, and clarifying liability frameworks.
Keywords
References
- Keskinbora KH. Medical ethics considerations on artificial intelligence. Journal of Clinical Neuroscience. 2019; 64: 277-282. doi: 10.1016/j.jocn.2019.03.001
- Attia ZI, Kapa S, Lopez-Jimenez F, McKie PM, Ladewig DJ, Satam G, et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nature Medicine. 2019; 25(1): 70-74. doi: 10.1038/s41591-018-0240-2
- Watson DS, Krutzinna J, Bruce IN, Griffiths CE, McInnes IB, Barnes MR, Floridi L. Clinical applications of machine learning algorithms: Beyond the black box. British Medical Journal. 2019; 364: l886. doi: 10.1136/bmj. l886
- Zhang J, Zhang ZM. Ethics and governance of trustworthy medical artificial intelligence. BMC Medical Informatics and Decision Making. 2023; 23(1): 7. doi: 10.1186/s12911-023-02103-9
- Ching T, Himmelstein DS, Beaulieu-Jones BK, Kalinin AA, Do BT, Way GP, et al. Opportunities and obstacles for deep learning in biology and medicine. Journal of the Royal Society, Interface. 2018; 15(141): 20170387. doi: 10.1098/rsif.2017.0387
- Goodman KW, Litewka SG, Malpani R, Pujari S, Reis AA. Global health and big data: The WHO's artificial intelligence guidance. South African Journal of Science. 2023; 119(5-6): 14725. doi: 10.17159/sajs.2023/14725
- World Health Organization. Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models. Geneva: World Health Organization; 2025. ISBN: 978-92-4-008475-9
- Floridi L. The ethics of artificial intelligence: Principles, challenges, and opportunities. 1st ed., 2023; Oxford University Press, UK. ISBN 978-0-19-888309-8. doi: 10.1093/oso/9780198883098.001.0001
- Dias R, Torkamani A. Artificial intelligence in clinical and genomic diagnostics. Genome Medicine. 2019; 11: 1-12. doi: 10.1186/S13073-019-0689-8
- Pesheva, Ekaterina. A new artificial intelligence tool for Cancer. Harvard Medical School. 2024. 25 Shattuck Street, Boston, MA 02115617-432-1000
- Yadavar, Swagata. India is worse than Bhutan, Bangladesh in healthcare, ranks 145th globally, Business Standard. 2018.
- Koçak B, Ponsiglione A, Stanzione A, Bluethgen C, Santinha J, Ugga L, et al. Bias in artificial intelligence for medical imaging: Fundamentals, detection, avoidance, mitigation, challenges, ethics, and prospects. Diagnostic and Interventional Radiology. 2025; 31(2): 75-88. doi: 10.4274/dir. 2024.242854
- Kabir S, Hossain MS, Andersson K. A review of explainable artificial intelligence from the perspectives of challenges and opportunities. Algorithms. 2025; 18(9): 556. doi: 10.3390/a18090556
- European Commission. Artificial Intelligence in healthcare. Brussels: European Commission; 2024.
- Yadav N, Pandey S, Gupta A, Dudani P, Gupta S, Rangarajan K. Data privacy in healthcare: In the era of artificial intelligence. Indian Dermatology Online Journal. 2023; 14(6): 788-792. doi: 10.4103/idoj.idoj_543_23
- European Data Protection Supervisor. Health. EDPS. 2024.
- Information Commissioner’s Office (ICO). Google DeepMind and class action lawsuit/Royal Free data sharing. ICO; 2017.
- van Kolfschooten H, van Oirschot J. The EU Artificial Intelligence Act (2024): Implications for healthcare. Health Policy. 2024; 149: 105152. doi: 10.1016/j.healthpol.2024.105152
- Rahimzadeh V. US regulation of medical artificial intelligence and machine learning (AI/ML) research and development. In: Solaiman B, Cohen IG, Eds. Research Handbook on Health, AI and the Law. Cheltenham, UK: Edward Elgar Publishing Ltd; 2024. Bookshelf ID: NBK613220. doi: 10.4337/9781802205657.ch16
- U.S. Food and Drug Administration. Draft guidance: Artificial intelligence-enabled device software functions: Lifecycle management and marketing submission recommendations. 2025.
- European Union. Artificial Intelligence Act. Entered into force Aug 1st, 2024.
- Abdullah YI, Schuman JS, Shabsigh R, Caplan A, Al-Aswad LA. Ethics of artificial intelligence in medicine and ophthalmology. The Asia-Pacific Journal of Ophthalmology (Phila). 2021; 10(3): 289-298. doi: 10.1097/APO. 0000000000000397
- Pham T. Ethical and legal considerations in healthcare AI: Innovation and policy for safe and fair use. Royal Society Open Science. 2025; 12(5): 241873. doi: 10.1098/rsos.241873
- The Guardian. Royal Free breached UK data law in 1.6 m patient deal with Google DeepMind. 2017.
- U.S. Food and Drug Administration. Artificial Intelligence and Machine Learning (AI/ML)-enabled medical device list. FDA; 2025.
- Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023; 15(7): 1916. doi: 10.3390/pharmaceutics15071916
- Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery. 2019; 18(6): 463-477. doi: 10.1038/s41573-019-0024-5
- Strubell E, Ganesh A, McCallum A. Energy and policy considerations for deep learning in NLP. In: Proceedings of the 57th Annual Meeting of the Association for Computational Linguistics. 2019; 3645-3650, Florence, Italy. Association for Computational Linguistics.
- Lenarczyk G, Minssen T, Price N, Rai A. The future of AI regulation in drug development: A comparative analysis. Journal of Law and Biosciences. 2025; 12(2): lsaf028. doi: 10.1093/jlb/lsaf028
- Topol EJ. High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine. 2019; 25(1): 44-56. doi: 10.1038/s41591-018-0300-7
- Taddese AA, Addis AC, Tam BT. Data stewardship and curation practices in AI-based genomics and automated microscopy image analysis for high-throughput screening studies: Promoting robust and ethical AI applications. Human Genomics. 2025; 19(1): 16. doi: 10.1186/s40246-025-00716-x
- Drabiak K. Leveraging law and ethics to promote safe and reliable AI/ML in healthcare. Frontiers in Nucleolar Medicine. 2022; 2: 983340. doi: 10.3389/fnume.2022.983340
- Akter B, Aishee S, Hridoy A, Pulok MMH, Islam MA, Biswas A, et al. Structural tailoring of etoricoxib: A spectrochemical, medicinal and pharmacological study. Chemical Physics Impact. 2025; 10, 100830. doi: 10.1016/ j.chphi.2025.100830
- Su J, Yang L, Sun Z, Zhan X. Personalized drug therapy: Innovative concept guided with proteoformics. Molecular and Cellular Proteomics. 2024; 23(3): 100737. doi: 10.1016/j.mcpro.2024.100737
- Hoque M. Mechanisms, clinical implications, and treatment strategies for autonomic health dysfunction in anxiety and depression. Batna Journal of Medical Sciences. 2025; 12(4): 28. doi: 10.48087/BJMSoa.2025.12428
- Gilbert S, Pimenta A, Stratton-Powell A, Welzel C, Melvin T. Continuous improvement of digital health applications linked to real-world performance monitoring: Safe moving targets? Mayo Clinic Proceedings: Digital Health. 2023; 1(3): 276-287. doi: 10.1016/j.mcpdig.2023.05.010
- Nizamuddin SFS, Ikramuddin M, Dhore NS. Artificial intelligence in pharmaceutical sciences: Transforming drug discovery, formulation, and manufacturing. Mediterranean Journal of Medical Research. 2025; 2(4): 269-275. doi. 10.5281/zenodo.17945149
- Luisetto M, Ferraiuolo A, Fiazza C, Cabianca L, Edbey K, Mashori GR, Latyshev OY. Artificial intelligence in the pharmaceutical galenic field: A useful instrument and risk consideration. Mediterranean Journal of Medical Research. 2025; 2(1): 10-19. doi: 10.5281/zenodo.15259824
- Oyeniyi JG. From lab to clinic: Addressing bias and generalizability in AI diagnostic systems. World Journal of Advanced Research and Reviews. 2025; 28(03): 2134-2179. doi: 10.30574/wjarr.2025.28.3.4249
Submitted date:
12/18/2025
Reviewed date:
02/16/2026
Accepted date:
02/20/2026
Publication date:
02/25/2026
